Clinical Trials Browser

UNKNOWN × Colorectal Neoplasms × HMPL-013 × Clear all

NCT05016869 2022-08-18

Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer

Phase 1/2 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT04695470 2021-01-07

Phase II Trial of Fruquintinib With Sintilimab in Treating Selected Refractory Metastatic Colorectal Cancer Patients

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms